Mental Health Watchdog Releases White Paper Questioning Antidepressant Prescribing Practices

Patients including a 24-year-old woman with a brain tumor were misdiagnosed with psychiatric conditions and prescribed inappropriate medications, causing harm and delayed proper medical treatment.
No one should accept a doctor who just listens and hands you a prescription.
A physician quoted in the watchdog's white paper on the importance of thorough medical evaluation before psychiatric diagnosis.
Mark

Why does this matter now? These concerns about psychiatric diagnosis aren't new.

Mimi

True, but the federal government just recommended deprescribing antidepressants nationwide. That's a policy shift. When HHS and state health offices start saying "slow down," it creates an opening to change how doctors actually practice.

Mark

The white paper mentions a brain tumor case and a 1989 study. Are those the strongest examples, or is there more recent evidence?

Mimi

Those are the anchors they lead with. The brain tumor cases are vivid—they show real harm from real misdiagnosis. The 1989 study is older, but it's official California data showing 80 percent of psychiatric patients had undiagnosed physical disease. That's hard to ignore.

Mark

But psychiatrists would say they do order tests. How do you know they're not already doing this?

Mimi

That's the tension. The organization is saying it's not standard practice, not universal. Some doctors do it well. Many don't. The Florida guidance and the federal recommendation suggest the current baseline isn't adequate.

Mark

What about the people already on antidepressants? Are they saying everyone should stop?

Mimi

No. They're saying safe, gradual withdrawal matters, and that informed consent matters. You need to know what you're taking and why. But the main push is prevention—catch the physical disease before you start the psychiatric drug.

Mark

This organization is tied to Scientology. Does that change how you read the argument?

Mimi

It's worth noting, yes. But the data points they cite—the California study, the federal recommendations, the brain tumor cases—those are independently verifiable. The argument stands or falls on evidence, not on who's making it.

Mark

What happens next? Does this white paper change anything?

Mimi

It depends on whether doctors and policymakers treat it as a wake-up call or dismiss it as activism. The federal deprescribing plan is already in motion. If states follow Florida's lead, you could see mandatory medical testing become standard before psychiatric drugs are prescribed. That would be a real shift.

  • Over 76 million Americans are on psychiatric drugs, including 2.1 million children prescribed antidepressants despite documented links to increased suicide risk in young people.
  • A 1989 California study found that 80% of psychiatric patients had undiagnosed physical diseases — some caused by the psychiatric drugs themselves — raising urgent questions about what is being treated and why.
  • Patients like a 24-year-old Yorkshire woman spent months worsening on antipsychotics before emergency imaging revealed a brain tumor, illustrating the human cost of skipping thorough medical evaluation.
  • Federal and state governments are beginning to respond — RFK Jr. has called for a national deprescribing plan, and Florida has issued guidance discouraging psychotropic drug use in children ages five through seventeen.
  • The watchdog group is pushing for mandatory physical examinations and biological testing before any psychiatric diagnosis, arguing that the current system's subjectivity creates dangerous incentives to over-diagnose and over-prescribe.

Across America, more than 76 million people take psychiatric drugs, yet the foundational question of whether a physical illness might be driving their symptoms often goes unasked. A mental health watchdog organization is pressing for a return to diagnostic discipline — arguing that before any psychiatric label is applied or medication prescribed, medicine must first look inward at the body itself. The cases of patients treated for years with psychiatric drugs while harboring undetected brain tumors remind us that the boundary between mind and body is not a wall, but a threshold requiring careful crossing.

A Los Angeles-based mental health watchdog released a sweeping white paper this week arguing that America's psychiatric prescribing system routinely skips a critical step: ruling out physical disease before reaching for a diagnosis and a prescription. The Citizens Commission on Human Rights International contends that the symptoms of depression — fatigue, weight loss, disrupted sleep — are indistinguishable from those of diabetes, cancer, or a growing tumor, and that without biological testing, the difference is too often left to guesswork.

The scale of the concern is hard to dismiss. More than 76 million Americans currently take psychiatric drugs, including 6.1 million children and teenagers. Among those, 2.1 million children are on antidepressants despite evidence linking them to elevated suicide risk in young people. The organization's call for reform has found unexpected institutional allies: in May, Health Secretary Robert F. Kennedy Jr. announced a national deprescribing initiative focused on reducing psychiatric drug use in children, and Florida issued guidance in July recommending against psychotropic drugs for minors aged five through seventeen.

The human stakes are vivid. One patient endured five years of psychiatric treatment for headaches and an unsteady gait before a brain tumor was finally discovered. More recently, Sarah-Jane Doherty, a 24-year-old from Yorkshire, was diagnosed as bipolar and prescribed an antipsychotic that worsened her condition — until emergency doctors ordered imaging in June 2026 and found a tumor requiring surgery. The watchdog argues these are not anomalies but predictable outcomes of a system that treats behavior as the primary diagnostic evidence.

The organization, founded in 1969, points to a 1989 California pilot study it helped establish, which found that 80 percent of psychiatric patients screened had undiagnosed physical conditions driving their symptoms — some of those conditions caused by the psychiatric drugs themselves. Its central demand is straightforward: no psychiatric diagnosis, and no prescription, without a thorough physical examination and investigation of underlying medical causes first. The current federal momentum, the group argues, offers a rare opening to make that standard the law of the land.

A mental health watchdog organization released a sweeping critique this week of how antidepressants are prescribed in America, arguing that doctors too often hand out psychiatric medications without first ruling out treatable physical diseases that can masquerade as mental illness. The Citizens Commission on Human Rights International, based in Los Angeles, published a white paper titled "Antidepressants: A Public Health Catastrophe – Evidence of Harm, Decades of Cover-Up, and the Urgent Need for Reform," making the case that mandatory medical testing should become standard practice before any psychiatric diagnosis or drug treatment is pursued.

The numbers are substantial. Over 76 million Americans currently take psychiatric drugs, including roughly 45 million on antidepressants. Among those are 6.1 million children and teenagers, with 2.1 million prescribed antidepressants despite evidence linking these drugs to increased suicide risk in young people. The organization's argument gains some institutional weight from recent federal action: in May, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recommended a nationwide deprescribing plan focused on reducing psychiatric drug use, particularly in children, with emphasis on informed consent, prevention, and safe withdrawal. In July, Florida's state health office issued guidance recommending against psychotropic drugs for children ages five through seventeen, emphasizing that any discontinuation must be gradual.

The core concern centers on diagnostic precision. Psychiatric diagnoses, unlike most medical conditions, rely on subjective observation of behavior and mood rather than blood tests or biological markers. The organization points out that the symptoms of major depressive disorder—weight loss, fatigue, sleep disturbance—are identical to symptoms of diabetes, cancer, and other treatable diseases. When a doctor sees these signs, the question of whether to prescribe psychiatric medication or order a CT scan becomes crucial. The watchdog cites a 1989 California pilot study, which it helped establish in 1982, showing that 80 percent of psychiatric patients screened had undiagnosed physical diseases, many of which were causing their psychiatric symptoms. Some of those abnormalities were actually induced by the psychiatric drugs themselves.

Two cases illustrate the human stakes. One patient spent five years in psychiatric treatment for headaches, dizziness, and an unsteady gait before a medical examination revealed a brain tumor. More recently, Sarah-Jane Doherty, a 24-year-old from Yorkshire in England, experienced exhaustion, depression, psychosis, hallucinations, mood swings, vision problems, and electric-shock sensations in her arm. She was diagnosed as bipolar and prescribed an antipsychotic that made her worse. In June 2026, emergency care doctors ordered imaging scans that revealed a brain tumor requiring surgery. Had thorough medical evaluation happened first, the misdiagnosis and inappropriate medication might have been avoided.

The organization's argument draws on decades of observation. Founded in 1969, it has worked on mental health policy issues for 57 years and helped pass more than 190 reforms worldwide. It notes that the American Psychiatric Association's diagnostic manual has progressively broadened the boundaries of psychiatric categories with each revision, raising questions about whether diagnoses have become less precise rather than more so. The Cato Institute has observed that when diagnosis is subjective and payment depends on diagnosis, the system creates incentives to expand the definition of illness. Jan Eastgate, president of the watchdog group, stated that workable alternatives to psychiatric drugs exist and must be prioritized, and that the federal deprescribing initiative offers a chance to make mandatory medical testing standard practice nationwide.

The argument is not that antidepressants have no role, but that the current system often skips the foundational step of ruling out physical disease. A physician quoted in the white paper put it plainly: no one should accept a doctor who listens to a complaint and hands over a prescription without a thorough history, complete physical exam, and investigation of underlying medical causes. The organization concludes that protecting patients from unnecessary drug exposure begins with the discipline of proper diagnosis.

Workable alternatives to psychiatric drugging exist and must be prioritized. The evidence from Florida's guidance, the California pilot studies, and physicians shows that thorough medical evaluation routinely uncovers treatable physical causes and ends the need for mind-altering drugs.
— Jan Eastgate, President of CCHR International
Nous contacter FAQ